Q3 2025 Trading Update and Grant of Options

AI SummaryClose X

ProBiotix Health PLC announced a Q3 2025 trading update showing continued strong progress. Sales increased by 30% to £1.97 million, up from £1.52 million in 2024. Gross profit rose by 21% to £1.06 million compared to £874k in the previous year, although the gross profit margin decreased to 54% from 58% due to a small stock write down. The company's forward order book is at record levels. Additionally, the board issued 700,000 options to senior management, exercisable at 9.5p per share, with a 10-year term contingent on achieving revenue targets; simultaneously, 500,000 options lapsed due to a management retirement.

Disclaimer*

UK 100

Latest directors dealings